









Markets
/
Stocks
/
nasdaq-esta
/

Establishment Labs Holdings Inc

ESTA

68.790USD

+2.430+3.66%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

2.00BMarket Cap

LossP/E TTM



Establishment Labs Holdings Inc

68.790

+2.430+3.66%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Establishment Labs Holdings Inc

Currency: USD Updated: 2026-02-06

Key Insights

Establishment Labs Holdings Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 43 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 83.25.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Establishment Labs Holdings Inc's Score

Industry at a Glance

Industry Ranking

43 / 205

Overall Ranking

133 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Negative

Establishment Labs Holdings Inc Highlights

StrengthsRisks

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

Undervalued

The company’s latest PE is -24.16, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 30.64M shares, decreasing 0.02% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 62.75K shares of this stock.

Analyst Rating

Based on 8 analysts

Buy

Current Rating

83.250

Target Price

+20.43%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Establishment Labs Holdings Inc is 7.30, ranking 93 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 53.78M, representing a year-over-year increase of 33.70%, while its net profit experienced a year-over-year increase of 33.19%.

Score

Industry at a Glance

Previous score

7.30

Change



Financials

5.68

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.85

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

6.93

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

8.75

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.31

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Establishment Labs Holdings Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Establishment Labs Holdings Inc is 7.39, ranking 91 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -24.16, which is -68.25% below the recent high of -7.67 and -23.03% above the recent low of -29.72.

Score

Industry at a Glance

Previous score

7.39

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 43/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Establishment Labs Holdings Inc is 8.25, ranking 50 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 75.00, with a high of 85.00 and a low of 62.00.

Score

Industry at a Glance

Previous score

8.25

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 8 analysts

Buy

Current Rating

83.250

Target Price

+20.43%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Establishment Labs Holdings Inc

ESTA

Stryker Corp

SYK

Abbott Laboratories

ABT

Medtronic PLC

MDT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Establishment Labs Holdings Inc is 7.19, ranking 45 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 74.75 and the support level at 62.91, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.87

Change

0.32

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(5)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.472

Neutral

RSI(14)

50.573

Neutral

STOCH(KDJ)(9,3,3)

51.233

Neutral

ATR(14)

3.796

Low Volatility

CCI(14)

6.154

Neutral

Williams %R

47.316

Neutral

TRIX(12,20)

-0.077

Sell

StochRSI(14)

32.015

Buy

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

69.774

Sell

MA10

68.343

Buy

MA20

67.450

Buy

MA50

69.913

Sell

MA100

60.057

Buy

MA200

49.266

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Establishment Labs Holdings Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 125.86%, representing a quarter-over-quarter decrease of 5.37%. The largest institutional shareholder is Ron Baron, holding a total of 1.18M shares, representing 4.07% of shares outstanding, with 57.49% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

JW Asset Management, LLC

3.06M

-0.68%

RTW Investments L.P.

2.59M

+0.18%

Qatar Investment Authority

2.39M

+36.21%

Brown Advisory

2.17M

+1.02%

Mack (Daniel J.)

2.00M

+6993.73%

Nantahala Capital Management, LLC

1.97M

+11.15%

Findell Capital Management LLC

1.30M

-6.09%

Baron Capital Management, Inc.

Star Investors

1.18M

+30.22%

Sariel, L.L.C.

1.13M

Lewin Nicholas Sheridan

1.12M

+0.05%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Establishment Labs Holdings Inc is 5.66, ranking 77 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.95. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Establishment Labs Holdings Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.